To study the effect of fish consumption on the risk of acute coronary syndrome (ACS) in healthy subjects.
Introduction
A very low incidence of coronary heart disease (CHD) was reported in Greenland Eskimos more than 35 years ago which was believed to be due to their extremely high intake of seafood rich in n23 polyunsaturated fatty acids (PUFA). 1, 2 Since then, data from other populations with a very high intake of seafood such as Alaskan Natives 3 and Japanese fishermen 4 have supported the hypothesis that marine n23 PUFA may protect against atherosclerosis, thrombosis, and CHD. 5 Studies in Western populations with a low or moderate intake of fish have been associated with lower coronary mortality, 6 -10 while the effect of seafood on non-fatal myocardial infarction (MI) and other manifestations of CHD has been less consistent. 11 Few studies have examined the effect of fish consumption on acute coronary syndrome (ACS) which includes patients with unstable angina pectoris, ST-elevation MI, non-ST-elevation MI, and fatal MI. 12 Recently, however, significantly lower blood levels of n23 PUFA were found in patients admitted with ACS compared with controls, 13, 14 suggesting a possible protective effect of n23
PUFA against ACS.
We have examined the association between lean and fatty fish intake and the risk of ACS in a large prospective study in Denmark. Information on fish consumption was obtained using a detailed and carefully validated food frequency questionnaire allowing separate effects of fish high and low in n23 PUFA to be investigated.
Methods

Study cohort
The Diet, Cancer and Health cohort was established by the Danish Cancer Society in 1993 -97 when 57 053 participants enrolled into a prospective study. Patients were, for this study, followed until the end of 2003, with a mean follow-up period of 7.6 years. The study participants were aged between 50 and 64 years, born in Denmark, and without a cancer diagnosis registered in the Danish Cancer Registry at baseline. The study was conducted in accordance with the Helsinki Declaration II and approved by the regional Ethics Committees. The study design has been reported in detail elsewhere. 15 
Dietary assessment
Information on the dietary habits during the previous year was obtained from a detailed, semi-quantitative 192-item food frequency questionnaire. Participants were asked to estimate their daily intake of foods that come in natural units, such as slices of bread, pieces of fruit, and cups and glasses of different beverages. For other foods, such as mixed dishes, a sex-specific portion size was calculated based on the results from a calibration study. By multiplying the frequencies of intake by the portion size, an individual average intake in grams/day of all foods and nutrients was calculated. A detailed description of the questionnaire and its validation has been published previously. 16, 17 A total of 24 foods and recipes in the food frequency questionnaire covered intake of fresh and processed fish specified according to preparation method. The different species of fish were categorized as either lean or fatty fish according to their content of n23 PUFA below or above 1 g/100 g based on data from the Danish Food Composition Databank (Table 1) .
Covariates
Participants completed a lifestyle questionnaire regarding their health status, lifestyle habits, and social factors. Non-fasting serum total cholesterol and blood pressure were measured at baseline along with anthropometrical measurements. 15 
Acute coronary syndrome
The Danish National Patient Registry covers all hospital discharge diagnoses in Denmark since 1977 and all discharge diagnoses from outpatient clinics since 1995. Identification of cases with ACS has been described in detail elsewhere. 18 Briefly, we identified cases of ACS in the cohort who were registered with an incident diagnosis of ACS (ICD-8: 410.00-410.99 and 427.27; ICD-10: I20.0, I21.0 -I21.9, and I46.0 -I46.9) during the study period. All medical records were reviewed by one of two physicians (A.M.J. and S.P.J.) to ensure that each case fulfilled the criteria of ACS used by the American Heart Association and the European Society of Cardiology. 12 Since the first symptom of ACS may be fatal MI, we also included participants who were coded in the Causes of Death Registry as dying from ACS.
Regarding sudden deaths outside hospitals, only cases with witnessed symptoms suggestive of coronary origin, a history of CHD, or indicative autopsy findings were included, whereas subjects who died suddenly without these characteristics were not included.
Statistical analyses
The association between fish intake and the risk of ACS was assessed using Cox' proportional hazard models with age as the time axis. Time in study was included as time-varying binary covariate, allowing the hazard ratio (HR) to change after 1 year in the study. For model diagnostics, we used a log-rank test in addition to graphical inspection of smoothed scaled Schoenfeld residuals. Analyses were performed separately for men and women.
In separate crude models, total intake of fish, fatty fish, and lean fish was included as categorical variables where the intake was split into quintiles according to the distribution of intake among cases. Total ACS and fatal MI were considered as outcomes. In adjusted models, we included baseline values of established risk factors for ACS: school education (short: 7 years, medium: 8 -10 years, and long: ; history of diabetes mellitus (yes, no); systolic blood pressure; serum cholesterol and physical activity (,30 and 30 min/day); dietary intake of fruits (g/day) and vegetables (g/day); total energy intake (MJ/day); and dietary intake of saturated fat (g/day), monounsaturated fat (g/day), and polyunsaturated fat (g/day). For women, we also adjusted for menopausal status (pre-or post-menopausal). In supplementary analyses, we stratified by the intake of fish oil capsules (yes, no). We used Stata version 9.2 (Stata Corporation, College Station, TX, USA) for statistical analyses.
Results
A total of 160 725 potential study participants were invited and the invitation was accepted by 27 178 men and 29 875 women. Participants who did not appear in the Cancer Registry but were identified with a cancer diagnosis in The Danish National Patient Registry before inclusion in the study (n ¼ 606) were excluded. We also excluded 1013 participants with a diagnosis of ACS prior to enrolment into the study. Furthermore, 103 participants were excluded due to missing medical records together with 20 patients where a medical-related procedure may have caused ACS. Finally, we excluded 1085 participants for whom information on one or more covariates used in adjusted analyses was missing. This left a total of 54 226 participants (25 573 men and 28 653 women) eligible for analysis. During 7.6 years of follow-up, a total of 1122 cases (854 men and 268 women) were verified. Table 2 shows the sex-specific baseline characteristics of the cohort. The median intake of fish was 35 g/day among women and 42 g/day among men. The prevalence of several established risk factors for cardiovascular disease (age, high cholesterol levels, smoking, and overweight) was higher among cases compared with the cohort as a whole.
The sex-specific HRs are given for crude and adjusted analyses of fish intake ( Table 3) . For total fish intake, no consistent associations were found, whereas we identified a protective association for fatty fish consumption in men. For lean fish, there was no effect in men, but the results may suggest a tendency for a protective association in women. Results from adjusted analyses did not differ substantially from crude analyses and allowing the HR to change after 1 year of follow-up indicated no effect modification by time. When we considered fatal MI (n ¼ 175) as an outcome, the associations were similar to those of intake of fish (total, fatty, and lean fish) and ACS, but the confidence intervals (CIs) were wider and no association was statistically significant (data not shown). Stratification according to intake of fish oil capsules did not significantly change the risk estimates (data not shown).
Discussion
In this prospective cohort study, intake of fatty fish was associated with a significant 30% lower risk of ACS in men during a mean follow-up period of 7.6 years when comparing subjects in the lowest quintile (6 g fatty fish/day) with those in the higher quintiles of intake. No clear dose-response relationship was, however, found, and a higher intake of fatty fish was not associated with a further lowering of the risk of ACS. Among men, no association was observed for lean fish intake. For women, a tendency for a lower risk of ACS was observed in the top quintile of intake of both fatty and lean fish. However, the number of female cases was low (n ¼ 268) and the CIs were wide. The strengths of this study include the follow-up study design, the detailed and validated food frequency questionnaire, the large number of cases, and the strict validation of the diagnosis ACS. The food frequency questionnaire used in our study was selfadministered and has been validated and tested against two 7-day weighed diet records. 16 Fish intake and acute coronary syndrome from this cohort comparing fatty acid profiles in adipose tissue biopsies with dietary intake of fatty acids showed significant correlations between the content of marine n23 PUFA in adipose tissue and that calculated from the food frequency questionnaire. 19 Some limitations also need to be considered. The food frequency questionnaire data representing the average diet the previous year are determined with some uncertainty. All data were only assessed at baseline and the participants' diets and risk factors may have changed during the study. There were few cases of fatal MI and few cases in women which make interpretation of results in these two groups difficult. Also, a diagnosis of ACS outside hospital is dubious, but accounted for ,10% (111/ 1122) of the cases in the present study. Moreover, it was not possible to define whether the cases of fatal MI also fulfilled the criteria of sudden cardiac death (death within 1 h from onset of cardiac symptoms). Therefore, the study provides little information about a possible effect of fish consumption on arrhythmias and sudden cardiac death. Finally, individuals with a higher fish intake generally exercise more, smoke less, and are less likely to be overweight. 20 Adjustment for lifestyle including diet did, however, not substantially change the associations, and residual confounding is therefore not a likely explanation for the observed associations.
The effect of fish consumption on CHD has been studied in other large epidemiological studies. Thus, in the Nurses' Health Study 21 comprising female nurses followed for 16 years, women in the highest quintile of fish intake (5 times a week) had a 21% lower risk of death from CHD compared with those in the lowest quintile (fish intake less than once a month). We have no explanation for the difference in findings between this very large study and our study. Most other trials in women 5, 6, 11 have included relatively few cases and the findings have not been consistent. Fish consumption was related to a relatively low risk of total mortality and sudden cardiac death, but not with a lower risk of MI or cardiovascular mortality in the Physicians' Health Study of 20 551 healthy men followed for 11 years. 22 There were 194 cases of MI and chest pain in a study of Finnish men initially free of CHD during 10 years of follow-up, with 44% fewer events in subjects in the highest quintile of serum n23 PUFA compared with those in the lowest quintile. 23 In a study of Chinese men, those who ate 50 g of fish/shellfish per week had a 44% lower risk of fatal MI compared with those who consumed less fish. 24 Furthermore, in a study of healthy Japanese men and women aged 40-59 years followed for 11 years, there was a 37% lower risk of fatal and non-fatal CHD and a 56% lower risk of definite MI in those in the highest quintile of fish intake (median 180 g/day) compared with those in the lowest quintile (median 23 g/day). 4 In contrast, no difference was seen in fatal or non-fatal CHD between the group with the highest fish intake (mean intake 119 g/day) and the group with no intake of fish in the Health Professionals Study of men aged 40-75 years during 6 years of follow-up. Incidence rate ratios and 95% CIs. a Adjusted for education, smoking, alcohol intake, body mass index, history of diabetes mellitus, systolic blood pressure, serum cholesterol, physical activity, dietary intake of fruits and vegetables, total energy intake, dietary intake of saturated fat, monounsaturated fat, and polyunsaturated fat. Analyses in women were also adjusted for menopausal status.
In a meta-analysis by He et al., 6 subjects who consumed fish at least once a month had a lower mortality from CHD than individuals with a lower intake of fish. Thus, each 20 g/day higher intake of fish was related to a 7% lower risk of CHD mortality. A recent intervention trial from Japan, the JELIS trial, 26 included subjects (both with and without CHD) with hypercholesterolaemia who were randomized to treatment with low-dose statin with or without 1.8 g of purified eicosapentaenoic acid. The primary endpoint was a composite of fatal and non-fatal MI, unstable angina pectoris, percutaneous coronary interventions, or coronary artery bypass grafting during a mean follow-up period of 4.6 years. There was a borderline significant 18% reduction in major coronary events in the group of subjects without CHD at baseline supplemented with eicosapentaenoic acid. In secondary intervention trials with hard clinical endpoints, fatty fish 7 and fish oil capsules 8, 26, 27 had a beneficial effect on various endpoints, e.g. total mortality, 7 coronary mortality, 8 sudden cardiac death, 8 MI, 27 and major coronary events. 26 In contrast, patients with stable angina pectoris randomized to fatty fish twiceweekly had an increased risk of coronary mortality and sudden cardiac death. 28 There are many explanations for the discordant results obtained, not least differences in study design and methodology. Differences in the type of fish consumed and preparation methods 9,29 may further explain inconsistency in the relation between fish intake and CHD across populations. Specific data on the different types of fish consumed in the studies are limited. Unlike most other studies, we have differentiated between lean and fatty fish, distinguishing according to the content of n23 PUFA and not according to the total amount of fat in fish. However, although sardines and tuna contain ,1 g/100 g of n23 PUFA based on The Danish Food Composition Tables and accordingly were classified as lean fish by us, they may in other studies be classified as fatty fish. However, tuna and sardines contributed little to the total fish intake in this Danish population (Table I ) and a putative different classification of them did not affect the results (data not shown).
Another explanation for the conflicting data from epidemiological studies may relate to an effect of pollutants. Some species of fish may contain environmental contaminants, where especially methylmercury has been brought into focus for its potential adverse effects on CHD. 5, 23, 30 On the other hand, the content of selenium in fish may protect against a toxic effect of methylmercury. 23, 30 Regarding mechanisms, marine n23 PUFA are incorporated into cell membrane phospholipids where they affect membrane function, cell signalling, arrhythmic properties, and a variety of other processes. 5,30 -32 Indeed, some data have indicated antithrombotic 4, 24, 26, 27 or antiarrhythmic 5, 8, 22, 33 effects of marine n23 PUFA, but results have not been uniform. 11 Furthermore, a stabilizing (anti-inflammatory) effect of marine n23 PUFA on human atherosclerotic plaques have also been reported. 34 Marine n23 PUFA also lower plasma triglycerides, impair platelet and leucocyte reactivity, lower heart rate, and may slightly reduce blood pressure, 5, 31, 32 although not convincingly shown for the very modest intake of fatty fish found to be protective in the present study. Finally, recent data suggest that fish consumption may decrease the risk of heart failure, a strong predictor of coronary events. 35, 36 Several effects of marine n23 PUFA may thus have contributed to the negative association between intake of fatty fish and ACS observed in the present study, perhaps not least a reduced incidence of clinically important plaque rupture/erosion with supervening thrombosis.
In conclusion, our study showed that a moderate intake of fatty fish is associated with a lower risk of ACS in middle-aged healthy men. Results among women were less consistent and further studies with more female cases are needed to clarify if fatty fish should be recommended for the prevention of ACS in women.
Funding
The Diet, Cancer and Health study was funded by the Danish Cancer Society. This study was funded by the Svend Andersen Foundation and the Danish Heart Association.
